221 related articles for article (PubMed ID: 8632606)
1. High levels of soluble p55-TNF receptors in seminal and prostatic fluids of normal and infertile men.
Tur-Kaspa I; Maor Y; Weissenberg R; Madgar I; Aderka D; Dor J; Mashiach S; Wallach D
J Urol; 1996 Apr; 155(4):1436-8. PubMed ID: 8632606
[TBL] [Abstract][Full Text] [Related]
2. The tumour necrosis factor family of receptors/ligands in the serum of patients with rheumatoid arthritis.
Robak T; Gladalska A; Stepień H
Eur Cytokine Netw; 1998 Jun; 9(2):145-54. PubMed ID: 9681390
[TBL] [Abstract][Full Text] [Related]
3. [Measurement of the serum concentrations of tumor necrosis factor alpha and its soluble receptors in normal and pre-eclamptic pregnant patients].
Núñez-González JR; Sanabria-Vera CJ; Romero-Adrián T
Invest Clin; 2001 Sep; 42(3):171-81. PubMed ID: 11552506
[TBL] [Abstract][Full Text] [Related]
4. [Soluble TNF p55 and p75 receptors in the development of sepsis syndrome].
Modzelewski B
Pol Merkur Lekarski; 2003 Jan; 14(79):69-72. PubMed ID: 12712835
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor-alpha and soluble tumor necrosis factor receptors in the culture supernatants of polymorphonuclear cells and peripheral blood mononuclear cells from cancer patients.
Jablońska E; Kiluk M; Piotrowski L; Grabowska Z; Markiewicz W; Jablonski J
Eur Cytokine Netw; 1998 Jun; 9(2):155-9. PubMed ID: 9681391
[TBL] [Abstract][Full Text] [Related]
6. The role of soluble TNF receptors for TNF-alpha in uveitis.
Sugita S; Takase H; Taguchi C; Mochizuki M
Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):3246-52. PubMed ID: 17591895
[TBL] [Abstract][Full Text] [Related]
7. Serum values of tumour necrosis factor-alpha and of soluble tumour necrosis factor-R55 in melanoma patients.
Ocvirk J; Stabuc B; Rudolf Z; Galvani V; Curin-Serbec V
Melanoma Res; 2000 Jun; 10(3):253-8. PubMed ID: 10890379
[TBL] [Abstract][Full Text] [Related]
8. Differences in tumor necrosis factor-alpha soluble receptor serum concentrations between patients with Henoch-Schönlein purpura and pediatric systemic lupus erythematosus: pathogenetic implications.
Gattorno M; Picco P; Barbano G; Stalla F; Sormani MP; Buoncompagni A; Gusmano R; Borrone C; Pistoia V
J Rheumatol; 1998 Feb; 25(2):361-5. PubMed ID: 9489835
[TBL] [Abstract][Full Text] [Related]
9. [Serum levels of soluble receptors for tumor necrosis factor in sarcoidosis].
Kawaguchi H; Ina Y; Sato S; Ito S; Sugiura Y; Hasegawa Y; Takada K; Yamamoto M; Morishita M
Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Aug; 33(8):850-5. PubMed ID: 7474565
[TBL] [Abstract][Full Text] [Related]
10. Plasma levels of tumor necrosis factor alpha and soluble tumor necrosis factor receptors in patients with narcolepsy.
Himmerich H; Beitinger PA; Fulda S; Wehrle R; Linseisen J; Wolfram G; Himmerich S; Gedrich K; Wetter TC; Pollmächer T
Arch Intern Med; 2006 Sep; 166(16):1739-43. PubMed ID: 16983052
[TBL] [Abstract][Full Text] [Related]
11. Effects of an intravenous catheter on the local production of cytokines and soluble cytokine receptors in healthy men.
Haack M; Reichenberg A; Kraus T; Schuld A; Yirmiya R; Pollmächer T
Cytokine; 2000 Jun; 12(6):694-8. PubMed ID: 10843747
[TBL] [Abstract][Full Text] [Related]
12. Soluble tumor necrosis factor (sTNF) receptors: a possible prognostic marker for bone marrow transplantation-related complications.
Or R; Kalinkovich A; Nagler A; Weisman Z; Naparstek E; Weiss L; Hahn T
Cytokines Mol Ther; 1996 Dec; 2(4):243-50. PubMed ID: 9384711
[TBL] [Abstract][Full Text] [Related]
13. [Significance of tumor necrosis factor-alpha gene polymorphism in patients with acute severe pancreatitis].
Zhang D; Li J; Jiang Z; Yu B; Tang X
Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(22):1529-31. PubMed ID: 12609060
[TBL] [Abstract][Full Text] [Related]
14. [Changes of proinflammatory cytokines and their receptors in serum from patients with pulmonary tuberculosis].
Tang S; Xiao H; Fan Y; Wu F; Zhang Z; Li H; Yang Y
Zhonghua Jie He He Hu Xi Za Zhi; 2002 Jun; 25(6):325-9. PubMed ID: 12126553
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of soluble receptors for tumor necrosis factor (p55 and p75 sTNFr) in endometrial cancer.
Gadducci A; Ferdeghini M; Fanucchi A; Annicchiarico C; Prato B; Prontera C; Facchini V; Genazzani AR
Anticancer Res; 1996; 16(5B):3125-8. PubMed ID: 8920779
[TBL] [Abstract][Full Text] [Related]
16. [Tumor necrosis factor alpha and its soluble receptors in serum of patients with coronary artery disease].
Mizia-Stec K; Mandecki T; Zahorska-Markiewicz B; Janowska J; Szulc A; Jastrzebska-Maj E; Szymański L
Pol Merkur Lekarski; 2001 Jul; 11(61):19-25. PubMed ID: 11579824
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor induced adhesion molecule serum concentrations in Henoch-Schönlein purpura and pediatric systemic lupus erythematosus.
Gattorno M; Vignola S; Barbano G; Sormani MP; Sabatini F; Buoncompagni A; Picco P; Pistoia V
J Rheumatol; 2000 Sep; 27(9):2251-5. PubMed ID: 10990243
[TBL] [Abstract][Full Text] [Related]
18. [Serum levels of tumor necrosis factor alpha and soluble tumor necrosis factor-receptor I in asthmatic patients and patients with chronic respiratory tract infection].
Sumitomo M; Suda S; Shindo K; Fukumura M; Fukushima J; Okuda K; Ito A
Arerugi; 1997 Nov; 46(11):1136-47. PubMed ID: 9436331
[TBL] [Abstract][Full Text] [Related]
19. Soluble TNF and IL-2 receptors in patients with breast cancer.
Tesarová P; Kvasnicka J; Umlaufová A; Homolková H; Jirsa M; Tesar V
Med Sci Monit; 2000; 6(4):661-7. PubMed ID: 11208388
[TBL] [Abstract][Full Text] [Related]
20. Diurnal and sleep-wake dependent variations of soluble TNF- and IL-2 receptors in healthy volunteers.
Haack M; Pollmächer T; Mullington JM
Brain Behav Immun; 2004 Jul; 18(4):361-7. PubMed ID: 15157953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]